← Back to Clinical Trials
Recruiting NCT07899034

NCT07899034 Music Therapy in Post-Stroke Patients: A Clinical Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07899034
Status Recruiting
Phase —
Sponsor Universidad de Granada
Condition CVA (Cerebrovascular Accident)
Study Type INTERVENTIONAL
Enrollment 84 participants
Start Date 2025-01-15
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Music therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 84 participants in total. It began in 2025-01-15 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if music therapy works to optimizate sleep quality in patients who have suffered a stroke. The main questions it aims to answer are: * What is the effect of music therapy on subjective sleep quality in stroke patients? * What is the effect of music therapy on the subjective perception of insomnia in stroke patients? * What is the effect of music therapy on levels of hospital anxiety and depression in stroke patients? * What is the level of satisfaction with the music therapy intervention? Researchers will compare an intervention group consisting of patients who will undergo music therapy with a control group of participants receiving standard care without music therapy sessions. Participants will: * Complete some questionaries about sleep quality (Pittsburgh Sleep Quality Index), inmsonia (Insomnia Severity Index), anxiety and depression associated with hospitalization (Hospital Anxiety and Depression Scale) before and after de intervention. * Intervention group receive daily 60-minute music therapy sessions at night during their hospitalization, whenever possible. * Intervention gruop have to report their perceived level of satisfaction with the music therapy.

Eligibility Criteria

Inclusion Criteria: * Diagnosis or suspected diagnosis of stroke. * Admission to the Neurology Department of the Hospital Universitario Clínico San Cecilio (HUCSC). * Score ≥ 5 on the Canadian Neurological Scale. * Preserved cognitive function. * Glasgow Coma Scale score ≥ 14. Exclusion Criteria: * Language impairment (aphasia). * Significant difficulties understanding the language. * Cognitive impairments affecting comprehension. * Acute psychiatric disorders and/or states of agitation. * Severe hearing impairment or profound deafness. * Diagnosis of obstructive sleep apnea. * Restless legs syndrome. * Chronic obstructive pulmonary disease. * Narcolepsy.

Contact & Investigator

Central Contact

Raquel Rodríguez Blanque Associated Proffesor at University of Granada, Nursing

✉ rarobladoc@ugr.es

📞 +34697958469

Frequently Asked Questions

Who can join the NCT07899034 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying CVA (Cerebrovascular Accident). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07899034 currently recruiting?

Yes, NCT07899034 is actively recruiting participants. Contact the research team at rarobladoc@ugr.es for enrollment information.

Where is the NCT07899034 trial being conducted?

This trial is being conducted at Granada, Spain.

Who is sponsoring the NCT07899034 clinical trial?

NCT07899034 is sponsored by Universidad de Granada. The trial plans to enroll 84 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology